MP & Design

View On IC.GC.CA

REGISTRATION PENDING

Last Applicant/ Owned by

Millicent Pharma Limited

Block 4, 2nd Floor Quayside Business ParkMills Street, Dundalk, County Louth, A91 KA9R

Serial Number

1969906 filed on 12^th Jun 2019

Correspondent Address

BHOLE IP LAW

130 Queens Quay East, Suite 1214Toronto

ONTARIO

M5A0P6

MP & Design

Trademark usage description

pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparat Read More

Vienna Information

27 . 1 . 1

Letters or numerals forming geometrical figures, written or typographical matter in perspectiveLettres ou chiffres formant des figures géométriques, inscriptions en perspective

27 . 1 . 16

Letters or numerals in perspective (decreasing towards the center, towards one extremity or towards both extremities)Lettres ou chiffres en perspective (décroissant vers le centre, vers l'une ou les deux extrémités)

29 . 1 . 4

BlueBleu

Classification Information

Class [005]
Pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment and management of vasomotor symptoms and symptoms associated with menopause; pharmaceutical preparations for the treatment of gastroenterological, intestine, bowel, stomach and digestive disorders; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders namely irritable bowel disorders and symptoms; pharmaceutical preparations for the treatment of genitourinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrhea and infertility; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone, androgen and estrogen disorders; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of prostate disorders; pharmaceutical preparations for treating the symptoms of menopause

Classification kind code

Class [010]
Implantable drug delivery device; implantable subcutaneous drug delivery devices; medical device, namely adhesive patches, for menstrual pain relief; medical device, namely, a pessary for the management of the symptoms of female stress urinary incontinence, urinary incontinence and prolapse of pelvic organs; medical devices for inter-vaginal use in administering a pharmaceutical agent, namely, a hormone, a spermicide, a protein, or a regenerative medicine; medical devices for the prevention of female stress urinary incontinence, urinary incontinence and prolapse of pelvic organs; medical devices for use treating or diagnosing urinary incontinence and prolapse of pelvic organs; medical intra-vaginal device, for therapeutic purposes; contraceptive coils; contraceptive diaphragms

Classification kind code

Mark Details

Serial Number

1969906

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 12 on 4^th Sept 2024	Extension of Time
Submitted for opposition 48 on 16^th Aug 2024	Agent Changed
Submitted for opposition 48 on 2^th Apr 2024	Agent Changed
Submitted for opposition 22 on 26^th Feb 2024	Search Recorded
Submitted for opposition 20 on 26^th Feb 2024	Examiner's First Report
Submitted for opposition 287 on 14^th Jun 2022	Pre-Assessment Letter Sent
Submitted for opposition 48 on 20^th May 2020	Agent Changed
Submitted for opposition 31 on 19^th Jun 2019	Formalized
Submitted for opposition 1 on 13^th Jun 2019	Created
Submitted for opposition 30 on 12^th Jun 2019	Filed